Telesair

Irvine, CA · Founded 2020 · Privately Held (backing)

Developer of respiratory therapy devices designed for delivering high flow oxygen therapy. Telesair is based in Irvine, CA and was founded in 2020. It was valued at $24 million at its later-stage round in Mar 2026, the last priced event on record. It has raised $25.9 million across 2 recorded rounds; the latest was a $3 million seed round in Feb 2026.

PMV mark · valuation
$24.0M
Oct 2026
Priced at
its later-stage round
Mar 2026
Total raised
$25.9M
Last round
Seed Round
Feb 2026

Telesair key facts

as of Oct 2026
  • Developer of respiratory therapy devices designed for delivering high flow oxygen therapy.
  • Telesair is valued at approximately $24.0M as of Oct 2026, set at its later-stage round, Mar 2026; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $25.9M across 2 recorded rounds; the latest was Seed Round ($3.0M) in Feb 2026.
  • Notable investors include ShangBay Capital, Berkeley Catalyst Fund Management, Device of Tomorrow Capital, Honeywell Ventures, Launchpad — 7 tracked in total.
  • Telesair has filed 1 Form D with the SEC, most recently Feb 2023 ($22.8M sold to 31 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
MEDIUM confidence
$24.0M

Valued at $24.0M at its later-stage round, Mar 2026. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Telesair with a free account
  • ·Watch Telesair: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Telesair funding rounds

2 rounds
Feb 2026Seed Round$3.0MSEC filing▮
Sep 2022Early Stage VC$22.8MSEC filing▮

Telesair valuation

Telesair was valued at $24 million at its later-stage round in Mar 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Telesair raised?

Telesair has raised $25.9 million across 2 recorded rounds since 2022. The largest was a $3 million seed round in Feb 2026.

Telesair has filed 1 Form D with the SEC, most recently in Feb 2023 ($22.8 million sold to 31 investors).

Telesair investors

7 investors are on record for Telesair, including ShangBay Capital, Berkeley Catalyst Fund Management, Device of Tomorrow Capital and Honeywell Ventures. The seed round in Feb 2026 drew 12 investors.

About Telesair

Developer of respiratory therapy devices designed for delivering high flow oxygen therapy. The company provides systems with integrated temperature control, regulated oxygen delivery, and consistent humidification, incorporates clinician-informed design and ventilation expertise, supports use across hospital and home environments, and enables healthcare providers to manage respiratory care with controlled airflow conditions and adaptable treatment settings.

Sector
Healthcare
HQ
Irvine, CA, United States
Founded
2020
Employees
31
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.